CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD.

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762

TW0001762003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
52.5 ^TWD	+0.57%		+5.32%	-8.54%

30/05	Chunghwa Chemical Synthesis & Biotech Co., Ltd. Elects Hou-Kai as Vice Chairman	CI
30/05	Chunghwa Chemical Synthesis & Biotech Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Approves Cash Dividend for the Year 2023

May 30, 2024 at 12:00 pm IST

Chunghwa Chemical Synthesis & Biotech Co., Ltd. at its AGM held on May 30, 2024, approved cash dividend to shareholders totals TWD 62,048,000. (The cash dividend is TWD 0.8 per share) for the year 2023.

Latest news about Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Elects Hou-Kai as Vice Chairman	30/05	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Approves Cash Dividend for the Year 2023	30/05	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. cancelled the transaction announced on March 11, 2024	11/03	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Cash Dividend for the Year 2022, Payable on August 18, 2023	27/23/27	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Cash Dividend for the Year 2022	30/23/30	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. announced a financing transaction	07/23/07	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Dividend, Payable on August 18, 2022	28/22/28	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Appointment of Kuan Arthur¡G as Independent Director	25/22/25	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Approves Cash Dividend for 2021	25/22/25	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/21/12	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14/21/14	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Cash Dividend, Payable on August 18, 2021	01/21/01	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	15/21/15	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	13/20/13	CI

Chart Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Duration

Period

Chart Chunghwa Chemical Synthesis & Biotech Co., Ltd.

More charts

Company Profile

CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

52.5 TWD

Average target price

48 TWD

Spread / Average Target

-8.57%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD.	-8.54%	13Cr
CSL LIMITED	+2.99%	9.52TCr
SAMSUNG BIOLOGICS CO.,LTD.	-4.34%	3.75TCr
BIOGEN INC.	-10.41%	3.38TCr
UCB	+75.79%	2.82TCr
BIOMARIN PHARMACEUTICAL INC.	-14.61%	1.56TCr
INCYTE CORPORATION	-3.46%	1.36TCr
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.31%	1.15TCr
ALTEOGEN INC.	+184.77%	1.08TCr
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54.13%	923.34Cr

Biopharmaceuticals